drugset
drugset / Trial / NCT00909571

Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus

NCT00909571 ↗

Phase 3 Completed 10 enrolled Astellas Pharma Inc Astellas Pharma Korea, Inc. · collab
RandomizedParallel-groupOpen-label

Summary

Tacrolimus pharmacokinetics study in primary living donor liver transplantation patients with Tacrolimus based immunosuppressive regimens.

Timeline

Start
2009-04
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — Oral
Subject Tacrolimus Small molecule — Other

Indications

No indication recorded.